Jove
Visualize
Contáctanos

Videos de Conceptos Relacionados

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
FDA Approved Drugs: Changes to Approved Drugs01:26

FDA Approved Drugs: Changes to Approved Drugs

Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

A Licensure Framework for Autonomous Clinical AI.

JAMA·2026
Same author

A randomized control trial of re-designed and shorter research informed consent forms to improve comprehension.

Clinical trials (London, England)·2026
Same author

A Machine Learning Model to Improve Risk Adjustment Accuracy in Medicare.

Health services research·2026
Same author

The paradox of trust in health care in the age of social media.

Lancet (London, England)·2026
Same author

Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records.

Nature communications·2026
Same author

Policy Agenda to Close the Hypertension Gap.

Journal of the American College of Cardiology·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Video Experimental Relacionado

Updated: Jun 6, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

El proceso de desarrollo farmacéutico basado en patentes: fundamentos, problemas y posibles reformas.

John H Barton1, Ezekiel J Emanuel

  • 1Department of Clinical Bioethics, National Institutes of Health, Bethesda, Md 20892-1156, USA.

JAMA
|October 27, 2005
PubMed
Resumen

El actual sistema de patentes para el desarrollo de fármacos limita el acceso y asigna mal los recursos. Las reformas como la fijación escalonada de precios y el aumento de la financiación pública podrían mejorar la accesibilidad a los medicamentos y la innovación.

Palabras clave:
Enfoque analítico El enfoque analítico.Investigaciones biomédicas y conductuales.Atención médica y salud pública.

Más Videos Relacionados

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

Videos de Experimentos Relacionados

Last Updated: Jun 6, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

Área de la Ciencia:

  • Industria farmacéutica La industria farmacéutica es la industria en la que se encuentran los productos farmacéuticos.
  • Economía de la salud Economía de la salud.
  • Política de desarrollo de drogas política de desarrollo de drogas.

Sus antecedentes:

  • La industria farmacéutica se enfrenta a críticas con respecto a los precios de los medicamentos, el acceso y las prioridades de investigación.
  • Existen preguntas fundamentales sobre el valor y la equidad del actual sistema de desarrollo de fármacos basado en patentes.
  • Los problemas incluyen barreras financieras para el acceso, altos beneficios y mala asignación de recursos.

Objetivo del estudio:

  • Evaluar críticamente el sistema de patentes existente para el desarrollo de fármacos.
  • Identificar los principales problemas dentro del sistema actual que afectan la accesibilidad a las drogas y la innovación.
  • Proponer posibles soluciones y reformas complementarias para un sistema más equitativo y efectivo.

Principales métodos:

  • Análisis del sistema de patentes de la industria farmacéutica y sus críticas asociadas.
  • Identificación de seis problemas principales con el actual modelo de desarrollo de fármacos basado en patentes.
  • Categorización de soluciones potenciales en precios, estructura de la industria e incentivos para el desarrollo.

Principales resultados:

  • El sistema de patentes puede obstaculizar el acceso a las drogas, distorsionar las prioridades de investigación hacia la demanda del mercado y conducir a una mala asignación de recursos.
  • El sistema puede resultar en una inversión general insuficiente en investigación y desarrollo en relación con los beneficios.
  • Los problemas existentes incluyen fallas de mercado y discriminación contra ciertas poblaciones de pacientes.

Conclusiones:

  • Se necesitan reformas para abordar el precio de los medicamentos, la estructura de la industria y los incentivos para el desarrollo.
  • Las reformas recomendadas incluyen pruebas comparativas posteriores a la aprobación, precios escalonados internacionales, mayor financiamiento gubernamental y sistemas de recompra.
  • Se sugieren experimentos específicos para condiciones con innovación limitada.